100 related articles for article (PubMed ID: 1665995)
1. Distribution and pharmacological characterization of muscarinic-cholinergic receptors in the cockroach brain.
Orr GL; Orr N; Hollingworth RM
Arch Insect Biochem Physiol; 1991; 16(2):107-22. PubMed ID: 1665995
[TBL] [Abstract][Full Text] [Related]
2. Evidence for muscarinic receptors on rat colonic epithelial cells: binding of [3H]quinuclidinyl benzilate.
Rimele TJ; O'Dorisio MS; Gaginella TS
J Pharmacol Exp Ther; 1981 Aug; 218(2):426-34. PubMed ID: 7252842
[TBL] [Abstract][Full Text] [Related]
3. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis.
Bellanger C; Halm MP; Dauphin F; Chichery R
Neurosci Lett; 2005 Oct; 387(3):162-7. PubMed ID: 16026931
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
5. Binding of N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4'-3H] quinuclidinyl benzilate to CNS extracts of the cockroach Periplaneta americana.
Lummis SC; Sattelle DB
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):75-83. PubMed ID: 2858352
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptors of the vascular bed: radioligand binding studies on bovine splenic veins.
Brunner F; Kukovetz WR
J Cardiovasc Pharmacol; 1986; 8(4):712-21. PubMed ID: 2427809
[TBL] [Abstract][Full Text] [Related]
7. Alterations in muscarinic cholinergic receptors after preganglionic denervation of the superior cervical ganglion in cats.
Taniguchi T; Kurahashi K; Fujiwara M
J Pharmacol Exp Ther; 1983 Mar; 224(3):674-8. PubMed ID: 6827488
[TBL] [Abstract][Full Text] [Related]
8. The binding characteristics of cholinergic sites in rabbit spermatozoa.
Young RJ; Laing JC
Mol Reprod Dev; 1991 Jan; 28(1):55-61. PubMed ID: 1994980
[TBL] [Abstract][Full Text] [Related]
9. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
Akiyama K; Vickroy TW; Watson M; Roeske WR; Reisine TD; Smith TL; Yamamura HI
J Pharmacol Exp Ther; 1986 Mar; 236(3):653-61. PubMed ID: 3005550
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
13. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
Marks MJ; Collins AC
Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem.
Kinney HC; Panigrahy A; Rava LA; White WF
J Comp Neurol; 1995 Nov; 362(3):350-67. PubMed ID: 8576444
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic cholinergic receptors on circulating human lymphocytes: evidence for a particulate binding site.
Bidart JM; Moingeon P; Bohuon C
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):169-72. PubMed ID: 6844735
[TBL] [Abstract][Full Text] [Related]
16. Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin.
Kurose H; Ui M
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):305-18. PubMed ID: 6687224
[TBL] [Abstract][Full Text] [Related]
17. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
Evans T; Martin MW; Hughes AR; Harden TK
Mol Pharmacol; 1985 Jan; 27(1):32-7. PubMed ID: 2981400
[TBL] [Abstract][Full Text] [Related]
18. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]